Zhuyu Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhuyu Li has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Zilian Wang
Department of Obstetrics and Gynecology, The first affiliated hospital, Sun Yat-sen University, Guangzhou, China
4 shared publications - Yun-Jiu Cheng
Department of Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2 shared publications Bo Sun
Department of Obstetrics and Gynecology, Shenzhen Second People's Hospital, Shenzhen, Guangdong, China
1 shared publication- Casper J. P. Zhang
School of Public Health, The University of Hong Kong, Hong Kong, China (Hong Kong)
1 shared publication - Changliu Xu
Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan 2nd Rd., Guangzhou 510080, China
1 shared publication - Chenxue Wang
Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan 2nd Rd., Guangzhou 510080, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Pregnancy
- Vol. 2026 (1) , e6113048
Selective Reduction of Multiple Pregnancies Into Singleton Pregnancy: Treatment Analysis for Fetal Position
Background: The rise in assisted reproductive technology has increased the prevalence of high‐risk triplet pregnancies. Dichorionic triamniotic (DCTA) triplets—where a monochorionic‐diamniotic (MCDA) twin pair shares a placenta—carry significant risks, including twin‐to‐twin transfusion syndrome. Although reducing a multifetal pregnancy to a singleton via MFPR leads to better outcomes, how the location of the reduced fetus within the uterus affects the success of the pregnancy is not addressed in current clinical guidance. Objectives: This study compares obstetric outcomes based on the location of the reduced MCDA twin pair (superior vs. inferior position) in DCTA triplet pregnancies. Methods: A retrospective analysis was conducted on 200 patients who underwent MFPR to a singleton between 2013 and 2024. Patients were divided into Group A (MCDA pair located farther from the cervix/superior) and Group B (MCDA pair located closer to the cervix/inferior). Primary outcomes included miscarriage rates (before 24 weeks) and gestational age at delivery. Results: Group A demonstrated a significantly lower miscarriage rate (4.1% vs. 17.9%, p = 0.001) and a higher mean gestational age at delivery (38.38 vs. 37.36 weeks, p = 0.015) compared to Group B. Additionally, the incidence of low birth weight was significantly lower in Group A (10.3% vs. 26.6%, p = 0.004). No significant differences were found in perinatal death or Apgar scores between the groups. Conclusions: In DCTA pregnancies, reducing the MCDA twin located farther from the cervix is associated with lower miscarriage rates and improved gestational outcomes.
- 1 January 2026
- Published by Wiley in Journal of Pregnancy
- Vol. 2026 (1) , e6113048
Open AccessSelective Reduction of Multiple Pregnancies Into Singleton Pregnancy: Treatment Analysis for Fetal Position
Background: The rise in assisted reproductive technology has increased the prevalence of high‐risk triplet pregnancies. Dichorionic triamniotic (DCTA) triplets—where a monochorionic‐diamniotic (MCDA) twin pair shares a placenta—carry significant risks, including twin‐to‐twin transfusion syndrome. Although reducing a multifetal pregnancy to a singleton via MFPR leads to better outcomes, how the location of the reduced fetus within the uterus affects the success of the pregnancy is not addressed in current clinical guidance. Objectives: This study compares obstetric outcomes based on the location of the reduced MCDA twin pair (superior vs. inferior position) in DCTA triplet pregnancies. Methods: A retrospective analysis was conducted on 200 patients who underwent MFPR to a singleton between 2013 and 2024. Patients were divided into Group A (MCDA pair located farther from the cervix/superior) and Group B (MCDA pair located closer to the cervix/inferior). Primary outcomes included miscarriage rates (before 24 weeks) and gestational age at delivery. Results: Group A demonstrated a significantly lower miscarriage rate (4.1% vs. 17.9%, p = 0.001) and a higher mean gestational age at delivery (38.38 vs. 37.36 weeks, p = 0.015) compared to Group B. Additionally, the incidence of low birth weight was significantly lower in Group A (10.3% vs. 26.6%, p = 0.004). No significant differences were found in perinatal death or Apgar scores between the groups. Conclusions: In DCTA pregnancies, reducing the MCDA twin located farther from the cervix is associated with lower miscarriage rates and improved gestational outcomes.
- Open Access
- 24 November 2025
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 22 (1)
Quercetin’s regulation of glucose and lipid metabolism in gestational diabetes mellitus: role of the PCSK9/LDLR axis
This study explored the ability of quercetin to improve glucose and lipid metabolism disorders induced by a high-fat diet (HFD) in a mouse model of gestational diabetes mellitus (GDM) on the basis of the PCSK9/LDLR axis and its potential molecular mechanisms. For the animal experiments, pregnant C57BL/6J mice were randomly divided into three groups: the control group (CD group), which was fed a standard diet; the model group (HFD group), which was fed a HFD; and the quercetin (CAS: 117–39–5) intervention group (HQ group), which was fed a HFD and given 75 mg·kg− 1·day− 1 quercetin by gavage. Moreover, we created an in vitro GDM hepatocyte model in which BNL CL.2 cells were cultured in high glucose and treated with 16 µM quercetin. The results showed that quercetin significantly improved glucose tolerance in GDM mice, reduced serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and proprotein convertase subtilisin/kexin type 9 (PCSK9) levels. It also alleviated hepatic steatosis and pancreatic islet cell hypertrophy. Additionally, it improved the abnormal weights of the placenta and fetus. In in vitro experiments, quercetin regulated the PCSK9/LDLR axis and activated the PI3K/AKT/GSK3β signaling pathway, increasing glucose uptake in liver cells. Molecular docking experiments confirmed that quercetin could directly occupy the PCSK9 catalytic pocket, with binding energies of -9.056 kcal mol− 1 for PCSK9 (human), -9. 193 kcal mol− 1 for PCSK9(mouse) and − 9.1 kcal mol− 1 for EGF-A interface of LDLR, which would sterically hinder LDLR interaction. This study revealed that quercetin improves glucose and lipid metabolism disorders in a GDM model by regulating the PCSK9/LDLR axis and the PI3K/AKT/GSK3β pathway. These findings support the potential use of quercetin as a treatment strategy for GDM.
- 24 November 2025
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 22 (1)
Open AccessQuercetin’s regulation of glucose and lipid metabolism in gestational diabetes mellitus: role of the PCSK9/LDLR axis
This study explored the ability of quercetin to improve glucose and lipid metabolism disorders induced by a high-fat diet (HFD) in a mouse model of gestational diabetes mellitus (GDM) on the basis of the PCSK9/LDLR axis and its potential molecular mechanisms. For the animal experiments, pregnant C57BL/6J mice were randomly divided into three groups: the control group (CD group), which was fed a standard diet; the model group (HFD group), which was fed a HFD; and the quercetin (CAS: 117–39–5) intervention group (HQ group), which was fed a HFD and given 75 mg·kg− 1·day− 1 quercetin by gavage. Moreover, we created an in vitro GDM hepatocyte model in which BNL CL.2 cells were cultured in high glucose and treated with 16 µM quercetin. The results showed that quercetin significantly improved glucose tolerance in GDM mice, reduced serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and proprotein convertase subtilisin/kexin type 9 (PCSK9) levels. It also alleviated hepatic steatosis and pancreatic islet cell hypertrophy. Additionally, it improved the abnormal weights of the placenta and fetus. In in vitro experiments, quercetin regulated the PCSK9/LDLR axis and activated the PI3K/AKT/GSK3β signaling pathway, increasing glucose uptake in liver cells. Molecular docking experiments confirmed that quercetin could directly occupy the PCSK9 catalytic pocket, with binding energies of -9.056 kcal mol− 1 for PCSK9 (human), -9. 193 kcal mol− 1 for PCSK9(mouse) and − 9.1 kcal mol− 1 for EGF-A interface of LDLR, which would sterically hinder LDLR interaction. This study revealed that quercetin improves glucose and lipid metabolism disorders in a GDM model by regulating the PCSK9/LDLR axis and the PI3K/AKT/GSK3β pathway. These findings support the potential use of quercetin as a treatment strategy for GDM.
- Open Access
- 4 November 2025
- Published by Springer Nature in Research Square
Prognostic Value of the Modified Classification of Selective Fetal Growth Restriction in Monochorionic Twins
Background The traditional Gratacós classification of selective fetal growth restriction (sFGR) provides essential information for prenatal surveillance, treatment strategies, and prognostic prediction. Alternatively, the Khalil-modified classification of sFGR integrates end-diastolic flow (EDF) in the umbilical artery (UA) and ductus venous (DV) Doppler parameters to further bolster its prognostic ability. However, the prognostic value of the Khalil-modified classification compared with the traditional classification remains unclear. Objective To assess the prognostic value of the Khalil-modified classification of sFGR for adverse perinatal outcomes (APOs) in monochorionic (MC) twins compared with the traditional Gratacós classification. In addition, differences in the prognostic accuracy at different time points during pregnancy were investigated. Study Design A retrospective analysis was conducted on MC twins suspected of having sFGR between April 2016 and April 2023 at our tertiary center. In the Khalil-modified classification, sFGR in MC twin pregnancies is classified into five progressive stages as follows: Stage 1 is characterized by positive EDF in the UA in the smaller twin; Stage 2a by persistent absent or reversed EDF (AREDF) in UA Doppler in the smaller twin; Stage 2b by intermittent AREDF in UA Doppler in the smaller twin; Stage 3 by abnormal DV Doppler findings in the smaller twin; Stage 4 by concurrent twin-to-twin transfusion syndrome (TTTS); and Stage 5 by intrauterine demise of the smaller twin. Herein, each enrolled case was classified using the traditional and modified classification at the initial diagnosis and the final examination. The accuracy of APO prediction was compared between these two classifications using receiver operating characteristic curves. P < 0.05 was considered as statistically significant. Results Herein, 272 MC twins with sFGR were included in the final analyses. At the final examination, 90 (33.1%) cases had Stage 1, 60 (22.1%) had Stage 2a, 34 (12.5%) had Stage 2b, 28 (10.3%) had Stage 3, and 60 (22.1%) had Stage 4 sFGR. sFGR Stages 2a and 3 were associated with a significantly higher risk of APOs than Stages 1 and 2b (78.3% and 92.9% vs. 23.3% and 50.0%; P < 0.001, P < 0.001, P = 0.003, and P = 0.002, respectively). The modified classification applied at the final examination exhibited the highest predictive capacity for APOs (area under the curve [AUC]: 0.735, 95.0% confidence interval [CI]: 0.687–0.786) compared with the Gratacós system (AUC: 0.656, 95.0% CI: 0.597–0.713) ( P = 0.011). Conclusions The modified classification system for sFGR in MC twins offers a useful tool with greater accuracy for risk stratification, particularly when used at the final examination. Additionally, it enables prenatal monitoring for the early identification of sFGR in MC pregnancies with poor prognosis and implementation of appropriate prenatal management strategies.
- 4 November 2025
- Published by Springer Nature in Research Square
Open AccessPrognostic Value of the Modified Classification of Selective Fetal Growth Restriction in Monochorionic Twins
Background The traditional Gratacós classification of selective fetal growth restriction (sFGR) provides essential information for prenatal surveillance, treatment strategies, and prognostic prediction. Alternatively, the Khalil-modified classification of sFGR integrates end-diastolic flow (EDF) in the umbilical artery (UA) and ductus venous (DV) Doppler parameters to further bolster its prognostic ability. However, the prognostic value of the Khalil-modified classification compared with the traditional classification remains unclear. Objective To assess the prognostic value of the Khalil-modified classification of sFGR for adverse perinatal outcomes (APOs) in monochorionic (MC) twins compared with the traditional Gratacós classification. In addition, differences in the prognostic accuracy at different time points during pregnancy were investigated. Study Design A retrospective analysis was conducted on MC twins suspected of having sFGR between April 2016 and April 2023 at our tertiary center. In the Khalil-modified classification, sFGR in MC twin pregnancies is classified into five progressive stages as follows: Stage 1 is characterized by positive EDF in the UA in the smaller twin; Stage 2a by persistent absent or reversed EDF (AREDF) in UA Doppler in the smaller twin; Stage 2b by intermittent AREDF in UA Doppler in the smaller twin; Stage 3 by abnormal DV Doppler findings in the smaller twin; Stage 4 by concurrent twin-to-twin transfusion syndrome (TTTS); and Stage 5 by intrauterine demise of the smaller twin. Herein, each enrolled case was classified using the traditional and modified classification at the initial diagnosis and the final examination. The accuracy of APO prediction was compared between these two classifications using receiver operating characteristic curves. P < 0.05 was considered as statistically significant. Results Herein, 272 MC twins with sFGR were included in the final analyses. At the final examination, 90 (33.1%) cases had Stage 1, 60 (22.1%) had Stage 2a, 34 (12.5%) had Stage 2b, 28 (10.3%) had Stage 3, and 60 (22.1%) had Stage 4 sFGR. sFGR Stages 2a and 3 were associated with a significantly higher risk of APOs than Stages 1 and 2b (78.3% and 92.9% vs. 23.3% and 50.0%; P < 0.001, P < 0.001, P = 0.003, and P = 0.002, respectively). The modified classification applied at the final examination exhibited the highest predictive capacity for APOs (area under the curve [AUC]: 0.735, 95.0% confidence interval [CI]: 0.687–0.786) compared with the Gratacós system (AUC: 0.656, 95.0% CI: 0.597–0.713) ( P = 0.011). Conclusions The modified classification system for sFGR in MC twins offers a useful tool with greater accuracy for risk stratification, particularly when used at the final examination. Additionally, it enables prenatal monitoring for the early identification of sFGR in MC pregnancies with poor prognosis and implementation of appropriate prenatal management strategies.
- Open Access
- 2 July 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-10
Noninvasive prediction of fetal growth restriction using maternal plasma cell-free RNA: a case-control study
Fetal growth restriction (FGR) is a significant concern due to its potential adverse outcomes for both mothers and infants. Cell-free RNA in maternal plasma has been suggested as a potential biomarker for pregnancy complications, but its effectiveness in predicting FGR remains uncertain. This study aimed to assess the predictive value of cell-free RNA profiling from maternal plasma collected during early to mid-pregnancy for FGR. This case-control study included pregnant women diagnosed with FGR who had non-invasive prenatal test data. Differentially expressed genes (DEGs) between FGR and controls groups were identified through the analysis of cell-free RNA and placental microarray dataset which downloaded from the Gene Expression Omnibus database. The intersection of DEGs from cell-free RNA and placenta was explored to explore hub genes. The least absolute shrinkage and selection operator regression was used to select the hub genes from the cell-free RNA DEGs. The prediction model was then constructed using logistic regression with hub genes and clinical characteristics. The predictive accuracy of model was evaluated using receiver operating characteristic analysis, calibration curves, and decision curve analysis. A total of 39 FGR samples and 133 control samples were included in this study. Among them, 405 cell-free RNA DEGs were identified. BIN2 was identified as the intersecting gene that was up-regulated in both cell-free RNA and FGR placental transcripts. Subsequently, RHOA and OAZ1 were selected by least absolute shrinkage and selection operator regression. The hub genes, including BIN2, RHOA and OAZ1, exhibited positive correlations with each other and were up-regulated in the FGR group. A logistic regression model incorporating the hub genes and clinical characteristics was constructed, achieving the highest classification performance with area under the curve of 0.812 (95% CI: 0.719–0.904) in the training cohort, 0.863 (95% CI: 0.736–0.989) in the validation cohort, and 0.786 (95% CI: 0.513–1.000) in the time test cohort. The calibration curve indicated good calibration of the model, and the decision curve analysis demonstrated practical value in clinical application. An effective prediction model for FGR was developed by integrating maternal plasma cell-free RNA with clinical characteristics, enabling early evaluation of FGR risk.
- 2 July 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-10
Open AccessNoninvasive prediction of fetal growth restriction using maternal plasma cell-free RNA: a case-control study
Fetal growth restriction (FGR) is a significant concern due to its potential adverse outcomes for both mothers and infants. Cell-free RNA in maternal plasma has been suggested as a potential biomarker for pregnancy complications, but its effectiveness in predicting FGR remains uncertain. This study aimed to assess the predictive value of cell-free RNA profiling from maternal plasma collected during early to mid-pregnancy for FGR. This case-control study included pregnant women diagnosed with FGR who had non-invasive prenatal test data. Differentially expressed genes (DEGs) between FGR and controls groups were identified through the analysis of cell-free RNA and placental microarray dataset which downloaded from the Gene Expression Omnibus database. The intersection of DEGs from cell-free RNA and placenta was explored to explore hub genes. The least absolute shrinkage and selection operator regression was used to select the hub genes from the cell-free RNA DEGs. The prediction model was then constructed using logistic regression with hub genes and clinical characteristics. The predictive accuracy of model was evaluated using receiver operating characteristic analysis, calibration curves, and decision curve analysis. A total of 39 FGR samples and 133 control samples were included in this study. Among them, 405 cell-free RNA DEGs were identified. BIN2 was identified as the intersecting gene that was up-regulated in both cell-free RNA and FGR placental transcripts. Subsequently, RHOA and OAZ1 were selected by least absolute shrinkage and selection operator regression. The hub genes, including BIN2, RHOA and OAZ1, exhibited positive correlations with each other and were up-regulated in the FGR group. A logistic regression model incorporating the hub genes and clinical characteristics was constructed, achieving the highest classification performance with area under the curve of 0.812 (95% CI: 0.719–0.904) in the training cohort, 0.863 (95% CI: 0.736–0.989) in the validation cohort, and 0.786 (95% CI: 0.513–1.000) in the time test cohort. The calibration curve indicated good calibration of the model, and the decision curve analysis demonstrated practical value in clinical application. An effective prediction model for FGR was developed by integrating maternal plasma cell-free RNA with clinical characteristics, enabling early evaluation of FGR risk.
- Open Access
Low Serum Creatinine Levels in Early Pregnancy Are Associated with a Higher Incidence of Postpartum Abnormal Glucose Metabolism among Women with Gestational Diabetes Mellitus: A Retrospective Cohort Study
The predictive factors for the progression from gestational diabetes mellitus (GDM) to type 2 diabetes remain incompletely elucidated. Our objective was to investigate the link between serum creatinine, a proxy for skeletal muscle mass, and the development of postpartum abnormal glucose metabolism (AGM). Methods: A retrospective review of the medical records of 501 women with GDM was conducted, all of whom underwent a 75 g oral glucose tolerance test (OGTT) between 4 and 12 weeks postpartum. Women were grouped based on quartiles of serum creatinine at the first antenatal visit to estimate the association between serum creatinine and postpartum AGM incidence. Results: Compared with the highest quartile of creatinine, lower quartiles were substantially linked to an increased incidence of postpartum AGM (adjusted odds ratios 3.37 [95% CI 1.77–6.42], 2.42 [95% CI 1.29–4.51] and 2.27 [95% CI 1.23–4.18], respectively). The generalized additive model suggested a linear relationship between serum creatinine levels and the risk of postpartum AGM below 68 µmol/L of serum creatinine levels. A decrease of 2 μmol/L in serum creatinine levels was found to be associated with a 10% increase in the odds of developing postpartum AGM. Linear regression revealed that a low serum creatinine level was linked to a higher postpartum 2-h glucose level and a decreased insulinogenic index (p = 0.007 and p = 0.027, respectively). Conclusions: An association was observed between lower serum creatinine levels in early pregnancy and an increased risk of postpartum AGM and poorer β-cell function in women with a recent history of GDM. Further research is needed to understand the mechanisms underlying our findings, as well as the role of skeletal muscle mass or nutritional status in early pregnancy on later glucose metabolism.
Open AccessLow Serum Creatinine Levels in Early Pregnancy Are Associated with a Higher Incidence of Postpartum Abnormal Glucose Metabolism among Women with Gestational Diabetes Mellitus: A Retrospective Cohort Study
The predictive factors for the progression from gestational diabetes mellitus (GDM) to type 2 diabetes remain incompletely elucidated. Our objective was to investigate the link between serum creatinine, a proxy for skeletal muscle mass, and the development of postpartum abnormal glucose metabolism (AGM). Methods: A retrospective review of the medical records of 501 women with GDM was conducted, all of whom underwent a 75 g oral glucose tolerance test (OGTT) between 4 and 12 weeks postpartum. Women were grouped based on quartiles of serum creatinine at the first antenatal visit to estimate the association between serum creatinine and postpartum AGM incidence. Results: Compared with the highest quartile of creatinine, lower quartiles were substantially linked to an increased incidence of postpartum AGM (adjusted odds ratios 3.37 [95% CI 1.77–6.42], 2.42 [95% CI 1.29–4.51] and 2.27 [95% CI 1.23–4.18], respectively). The generalized additive model suggested a linear relationship between serum creatinine levels and the risk of postpartum AGM below 68 µmol/L of serum creatinine levels. A decrease of 2 μmol/L in serum creatinine levels was found to be associated with a 10% increase in the odds of developing postpartum AGM. Linear regression revealed that a low serum creatinine level was linked to a higher postpartum 2-h glucose level and a decreased insulinogenic index (p = 0.007 and p = 0.027, respectively). Conclusions: An association was observed between lower serum creatinine levels in early pregnancy and an increased risk of postpartum AGM and poorer β-cell function in women with a recent history of GDM. Further research is needed to understand the mechanisms underlying our findings, as well as the role of skeletal muscle mass or nutritional status in early pregnancy on later glucose metabolism.
- 1 March 2023
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 98 (3) , 386-397
Systolic Blood Pressure and Cardiovascular Risk in Normotensive Adults
- 1 March 2023
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 98 (3) , 386-397
Systolic Blood Pressure and Cardiovascular Risk in Normotensive Adults
- Open Access
- 1 December 2020
- Published by Wiley in Clinical Cardiology
- Vol. 43 (12) , 1601-1608
Association of early repolarization pattern with cardiovascular outcomes in middle-aged population: A cohort study
Background Large cohort studies provide conflicting evidence regarding the prognostic value of early repolarization pattern (ERP) in the general population, complicated by the complex or heterogeneous definitions of ERP applied in different studies. Hypothesis We hypothesized that ERP was associated with increased cardiovascular risk with the definition of ERP recommended by the expert consensus statements. Methods A total of 13673 middle-aged subjects from the prospective, population-based Atherosclerosis Risk in Communities (ARIC) study were included in this analysis. Cox models were used to estimate the hazard ratios (HRs) adjusted for possible confounding factors. ERP was defined as ST-segment elevation >= 0.1mV at the end of the QRS or J wave on the QRS downstroke in two or more contiguous leads. Results Compared with those without ERP, subjects with ERP had a significantly increased risk of developing sudden cardiac death (SCD) (HR, 1.48; 95% CI, 1.08-2.04) and death from coronary heart disease (CHD) (HR, 1.45; 95% CI, 1.10-1.92) after a median follow-up of 20.1 years. ERP was significantly predictive of SCD in females, whites, younger people, and subjects with relatively low cardiovascular risk. ERP with ST-segment elevation appeared to indicate poor cardiovascular outcomes. ERP was associated with an absolute risk increase of 93.3 additional SCDs per 100 000 person-years. Conclusions Our findings suggest that ERP was an independent predictor of SCD and CHD death in the middle-aged biracial population.
- 1 December 2020
- Published by Wiley in Clinical Cardiology
- Vol. 43 (12) , 1601-1608
Open AccessAssociation of early repolarization pattern with cardiovascular outcomes in middle-aged population: A cohort study
Background Large cohort studies provide conflicting evidence regarding the prognostic value of early repolarization pattern (ERP) in the general population, complicated by the complex or heterogeneous definitions of ERP applied in different studies. Hypothesis We hypothesized that ERP was associated with increased cardiovascular risk with the definition of ERP recommended by the expert consensus statements. Methods A total of 13673 middle-aged subjects from the prospective, population-based Atherosclerosis Risk in Communities (ARIC) study were included in this analysis. Cox models were used to estimate the hazard ratios (HRs) adjusted for possible confounding factors. ERP was defined as ST-segment elevation >= 0.1mV at the end of the QRS or J wave on the QRS downstroke in two or more contiguous leads. Results Compared with those without ERP, subjects with ERP had a significantly increased risk of developing sudden cardiac death (SCD) (HR, 1.48; 95% CI, 1.08-2.04) and death from coronary heart disease (CHD) (HR, 1.45; 95% CI, 1.10-1.92) after a median follow-up of 20.1 years. ERP was significantly predictive of SCD in females, whites, younger people, and subjects with relatively low cardiovascular risk. ERP with ST-segment elevation appeared to indicate poor cardiovascular outcomes. ERP was associated with an absolute risk increase of 93.3 additional SCDs per 100 000 person-years. Conclusions Our findings suggest that ERP was an independent predictor of SCD and CHD death in the middle-aged biracial population.
- Open Access
- 12 November 2018
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 18 (1) , 1-9
The effect of exercise during pregnancy on gestational diabetes mellitus in normal-weight women: a systematic review and meta-analysis
Gestational diabetes mellitus (GDM) is one of the most common complications during pregnancy, and it has both short- and long-term adverse effects on the health of mothers and fetuses. To investigate the effect of exercise during pregnancy on the occurrence of GDM among normal-weight pregnant women. We searched for studies published between January 1994 and June 2017 that appeared in the Web of Science, Scopus, ClinicalTrials.gov or Cochrane library databases. Randomized controlled trials that investigated the preventive effect of exercise on GDM in normal-weight women were included. Interventions including any confounding factors (e.g., dietary) were excluded. We extracted maternal characteristics, the diagnostic criteria of GDM, and basic information for intervention and obstetric outcomes. The primary outcome was the occurrence of GDM, and the secondary outcomes included gestational weight gain, gestational age at birth, birth weight, and the odds of cesarean section. A meta-analysis was conducted based on calculations of pooled estimates using the random-effects model. Eight studies were included in this systematic review and meta-analysis. Exercise during pregnancy was shown to decrease the occurrence of GDM [RR = 0.58, 95% CI (0.37, 0.90), P = 0.01 and RR = 0.60, 95% CI (0.36, 0.98), P = 0.04 based on different diagnosis criteria, respectively] in normal-weight women. Regarding secondary outcomes, exercise during pregnancy can decrease gestational weight gain [MD = − 1.61, 95% CI (− 1.99, − 1.22), P<0.01], and had no significant effects on gestational age at birth [MD = − 0.55, 95% CI (− 1.57, 0.47), P = 0.29], birth weight [MD = − 18.70, 95% CI (− 52.49, 15.08), P = 0.28], and the odds of caesarean section [RR = 0.88, 95% CI (0.72, 1.08), P = 0.21], respectively. Exercise during pregnancy can ostensibly decrease the occurrence of GDM without reducing gestational age at delivery and increasing the odds of cesarean section in normal-weight women.
- 12 November 2018
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 18 (1) , 1-9
Open AccessThe effect of exercise during pregnancy on gestational diabetes mellitus in normal-weight women: a systematic review and meta-analysis
Gestational diabetes mellitus (GDM) is one of the most common complications during pregnancy, and it has both short- and long-term adverse effects on the health of mothers and fetuses. To investigate the effect of exercise during pregnancy on the occurrence of GDM among normal-weight pregnant women. We searched for studies published between January 1994 and June 2017 that appeared in the Web of Science, Scopus, ClinicalTrials.gov or Cochrane library databases. Randomized controlled trials that investigated the preventive effect of exercise on GDM in normal-weight women were included. Interventions including any confounding factors (e.g., dietary) were excluded. We extracted maternal characteristics, the diagnostic criteria of GDM, and basic information for intervention and obstetric outcomes. The primary outcome was the occurrence of GDM, and the secondary outcomes included gestational weight gain, gestational age at birth, birth weight, and the odds of cesarean section. A meta-analysis was conducted based on calculations of pooled estimates using the random-effects model. Eight studies were included in this systematic review and meta-analysis. Exercise during pregnancy was shown to decrease the occurrence of GDM [RR = 0.58, 95% CI (0.37, 0.90), P = 0.01 and RR = 0.60, 95% CI (0.36, 0.98), P = 0.04 based on different diagnosis criteria, respectively] in normal-weight women. Regarding secondary outcomes, exercise during pregnancy can decrease gestational weight gain [MD = − 1.61, 95% CI (− 1.99, − 1.22), P<0.01], and had no significant effects on gestational age at birth [MD = − 0.55, 95% CI (− 1.57, 0.47), P = 0.29], birth weight [MD = − 18.70, 95% CI (− 52.49, 15.08), P = 0.28], and the odds of caesarean section [RR = 0.88, 95% CI (0.72, 1.08), P = 0.21], respectively. Exercise during pregnancy can ostensibly decrease the occurrence of GDM without reducing gestational age at delivery and increasing the odds of cesarean section in normal-weight women.